BackSinovac Biotech, Overview

Sinovac Biotech, Research & Development

Research & Development expenses for SVA.

Quarterly R&D Expenses

$193.38M
↓ 24.96% YoY

As of Dec 31, 2023

Annual R&D Expenses (TTM)

$786.62M
↑ 328.32% YoY

Trailing 12 months ending Dec 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin